Sánchez-Valverde Félix, Etayo Verónica, Gil Francisco, Aznal Elena, Martínez Diana, Amézqueta Ana, Mendizábal Mikel, Galbete Arkaitz, Pastor Nítida, Vanderhoof Jon
Gastroenterology and Paediatric Nutrition Section, Hospital Complex of Navarra, Pamplona, Spain.
Study Group of Nutrition and Paediatric Digestive Diseases of Navarra, GENDINA, Navarra-Biomed, IDISNA, Pamplona, Spain.
Int Arch Allergy Immunol. 2019;179(4):290-296. doi: 10.1159/000499319. Epub 2019 May 16.
Cow's milk allergy (CMA) is a common diagnosis in infants, requiring the exclusion of cow's milk until tolerance is recovered. In the present study, we aim to determine which factors are associated with the development of tolerance.
Retrospective, observational study of subjects who underwent the same clinical follow-up methodology. We studied 245 cases of CMA (125 IgE-mediated and 120 non-IgE-mediated). The following variables were analysed: age at diagnosis, gender, type of delivery, type of feeding received, feeding during the first months of life, clinical features, and type of feed received as treatment: casein hydrolysates or casein hydrolysates with Lactobacillus rhamnosus GG (LGG).
Factors associated with earlier tolerance were non-IgE-mediated CMA (HR = 2.92; 95% CI: 2.20-3.88) and patients receiving casein hydrolysate with LGG (HR = 1.79; 95% CI: 1.33-2.42). Later tolerance was associated with caesarean delivery (HR = 0.78; 95% CI: 0.58-1.05) and breastfeeding for a period of at least 3 days (HR = 0.64; 95% CI: 0.44-0.93). The multivariate study shows that the type of formula (HR = 1.61; 95% CI: 1.19-2.18) and the type of CMA (HR = 2.82; 95% CI: 2.12-3.85) have an effect on the recovery time. Casein hydrolysates with LGG reduces the recovery time in IgE-mediated (HR = 1.88; 95% CI: 1.17-3.01) and non-IgE-mediated CMA (HR = 1.46; 95% CI: 0.98-2.17).
Tolerance acquisition is faster in non-IgE-mediated CMA subjects and in those who received casein hydrolysate with LGG.
牛奶过敏(CMA)是婴儿常见的诊断病症,在恢复耐受性之前需要避免食用牛奶。在本研究中,我们旨在确定哪些因素与耐受性的发展相关。
对采用相同临床随访方法的受试者进行回顾性观察研究。我们研究了245例CMA病例(125例为IgE介导型,120例为非IgE介导型)。分析了以下变量:诊断时的年龄、性别、分娩方式、接受的喂养类型、生命最初几个月的喂养情况、临床特征以及作为治疗所接受的喂养类型:酪蛋白水解物或含鼠李糖乳杆菌GG(LGG)的酪蛋白水解物。
与较早出现耐受性相关的因素为非IgE介导的CMA(风险比[HR]=2.92;95%置信区间[CI]:2.20 - 3.88)以及接受含LGG的酪蛋白水解物的患者(HR = 1.79;95% CI:1.33 - 2.42)。较晚出现耐受性与剖宫产(HR = 0.78;95% CI:0.58 - 1.05)以及母乳喂养至少3天(HR = 0.64;95% CI:0.44 - 0.93)相关。多变量研究表明,配方类型(HR = 1.61;95% CI:1.19 - 2.18)和CMA类型(HR = 2.82;95% CI:2.12 - 3.85)对恢复时间有影响。含LGG的酪蛋白水解物可缩短IgE介导型(HR = 1.88;95% CI:1.17 - 3.01)和非IgE介导型CMA的恢复时间(HR = 1.46;95% CI:0.98 - 2.17)。
非IgE介导型CMA患者以及接受含LGG的酪蛋白水解物的患者获得耐受性的速度更快。